H2020HORIZON
Breakthrough T1D
- Country
- USUnited States
- Defence projects
- 0
- Projects, all programmes
- 14
- As coordinator
- 0
- EU contribution (CORDIS)
- EUR 0
- Active
- 2015 to 2025
Projects
14 projects, newest first
| Project | Programme | Year | Role | EU contribution |
|---|---|---|---|---|
| READIResearch in Europe and Diversity Inclusion | HORIZON | 2025 | Participant | EUR 0 |
| NHPigReducing Non-Human Primates in Non-Clinical Safety Assessment: The European Initiative on Minipig and Micropig Models | HORIZON | 2024 | Participant | EUR 0 |
| iCARE4CVDINDIVIDUALISED CARE FROM EARLY RISK OF CARDIOVASCULAR DISEASE TO ESTABLISHED HEART FAILURE | HORIZON | 2023 | Participant | EUR 0 |
| ARTiDeAutoantigen-specific adoptive regulatory T cell therapy against type 1 diabetes (ARTiDe) | HORIZON | 2023 | Associated partner | EUR 0 |
| REDDIEReal-world evidence for decisions in diabetes | HORIZON | 2023 | Associated partner | EUR 0 |
| EDENT1FIEuropean action for the Diagnosis of Early Non-clinical Type 1 diabetes For disease Interception | HORIZON | 2023 | Participant | EUR 0 |
| MELISSAMobile Artificial Intelligence Solution for Diabetes Adaptive Care | HORIZON | 2022 | Participant | EUR 0 |
| INNODIA HARVESTTranslational approaches to disease modifying therapy of type 1 diabetes - HARVESTing the fruits of INNODIA | H2020 | 2020 | Participant | EUR 0 |
| H2OH2O Health Outcomes Observatory | H2020 | 2020 | Participant | EUR 0 |
| SOPHIAStratification of Obesity Phenotypes to Optimize Future Therapy | H2020 | 2020 | Participant | EUR 0 |
| imSAVARImmune Safety Avatar: nonclinical mimicking of the immune system effects of immunomodulatory therapies | H2020 | 2019 | Participant | EUR 0 |
| Hypo-RESOLVEHypoglycaemia - REdefining SOLutions for better liVEs | H2020 | 2018 | Participant | EUR 0 |
| BEAt-DKDBiomarker Enterprise to Attack DKD - Sofia ref.: 115974 | H2020 | 2016 | Participant | EUR 0 |
| INNODIATranslational approaches to disease modifying therapy of type 1 diabetes: an innovative approach towards understanding and arresting type 1 diabetes – Sofia ref.: 115797 | H2020 | 2015 | Participant | EUR 0 |
The country is the one the source records for the organisation’s registration (its PIC), and each profile says what it rests on. Where the record contradicts itself (the address in one country, the site name and the VAT number in another) we follow the two that agree: the Spanish research council CSIC is shown under Spain although its address is recorded in Italy. A body with sites in several countries is shown under the first of them in alphabetical order, and its profile lists the others. Beyond that we do not guess.
Where this comes from
- CORDIS: EU research projects (Horizon Europe, Horizon 2020, FP7)Last read on . Licence: Commission Decision 2011/833/EU (reuse of Commission documents). Source: CORDIS, European Commission.Participants and amounts as the Commission's CORDIS database states them (reuse under Commission Decision 2011/833/EU).
EU contribution is the amount CORDIS's open data pays to the participant. For a participant with linked third parties it may include their share (the CORDIS page prints the net); an amount the data does not hold is left out, not counted as zero. EDF factsheets state none per participant, so EDF projects count as projects but add nothing to the amounts.
Organisation-level facts only: a name, a country, a role, an amount, a year. A participant is recognised by its PIC where the source gives one, otherwise by name; the page says which. How the data is built.
Names are as CORDIS and the EDF project factsheets publish them. We do not list an organisation whose name looks like a natural person’s. If this entry is you, or a business named after you, and you want it removed, write to the contact in the imprint; the privacy notice (sections 7 and 9) says how a request is handled.